---
title: Effect of Postextubation High-Flow Nasal Cannula vs Noninvasive Ventilation in Patients With Hypercapnic COPD
nct_id: NCT03928535
overall_status: UNKNOWN
phase: NA
sponsor: Xiangya Hospital of Central South University
study_type: INTERVENTIONAL
primary_condition: High-Flow Nasal Cannula
countries: China
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03928535.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03928535"
ct_last_update_post_date: 2019-04-26
last_seen_at: "2026-05-12T07:34:41.609Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Effect of Postextubation High-Flow Nasal Cannula vs Noninvasive Ventilation in Patients With Hypercapnic COPD

**Official Title:** Effect of Postextubation High-Flow Nasal Cannula vs Noninvasive Ventilation on Reintubation and Postextubation Respiratory Failure in Patients With Hypercapnic COPD，a Randomized Controlled Trial

**NCT ID:** [NCT03928535](https://clinicaltrials.gov/study/NCT03928535)

## Key Facts

- **Status:** UNKNOWN
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 100
- **Lead Sponsor:** Xiangya Hospital of Central South University
- **Conditions:** High-Flow Nasal Cannula, COPD
- **Start Date:** 2016-05-01
- **Completion Date:** 2019-12-31
- **CT.gov Last Update:** 2019-04-26

## Brief Summary

To test if high-flow conditioned oxygen therapy is noninferior to NIV for preventing postextubation respiratory failure and reintubation in patients with hypercapnic COPD, investigators plan to conduct the participants level, 1:1 randomized trial at the respiratory ICU. Participants were randomized to undergo either high-flow conditioned oxygen therapy or noninvasive mechanical ventilation after extubation. Primary outcomes were reintubation and postextubation respiratory failure within 72 hours. Secondary outcomes included length of RICU stay after extubation and mortality; partial pressure of arterial carbon dioxide.

## Eligibility

- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Clinical diagnosis of AECOPD
* Extubation must be performed after 48 hours of invasive ventilation
* Must be treated sequentially with HFNC or NIV after extubation
* PaCO2≥50mmHg when extubation
* Positive End Expiratory Pressure (PEEP) ≤8cmH2O (1cmH2O=0.098 kPa) when extubation

Exclusion Criteria:

* Do-not-intubate
* Tracheostomies
* Accidental extubation
* Self-extubation
```

## Arms

- **High-Flow Nasal Cannula** (OTHER) — High-flow oxygen was applied immediately after extubation through specific nasal cannula.
- **Noninvasive Ventilation** (OTHER) — Noninvasive Ventilation was applied immediately after extubation.

## Interventions

- **High-FlowNasal Cannula** (DEVICE) — High-flowoxygenwas applied immediately after extubation through specific nasal cannula. Flow was initially set at 10 L/min and titrated upwards in 5-L/min steps until patients experienced discomfort.Temperature was initially set to 37°C, unless reported too hot by patients, and FIO2 was regularly adjusted to the target peripheral capillary oxygen saturation (SPO2) of greater than 92%. After 24 hours, high-flow was stopped and, if necessary, patients received conventional oxygen therapy.
- **Noninvasive Ventilation** (DEVICE) — Full face mask NIV was continuously delivered immediately after extubation for a scheduled period of 24 hours after extubation. Afterward, NIV was withdrawn and oxygen was administered by Venturi mask.Both PEEP and inspiratory pressure supportwere adjusted to target a respiratory rate of 25/min and adequate gas exchange (arterial oxygen saturation \[SaO2\] 92%, with pH of 7.35). The FIO2 was adjusted to maintain SPO2 at less than 92%. Sedatives to increase tolerance to NIV were not allowed.

## Primary Outcomes

- **Rate of reintubation** _(time frame: Within 72 hours after extubation)_ — The proportion of patients requiring reintubation within 72 hours after extubation

## Secondary Outcomes

- **RICU length of stay after extubation** _(time frame: From date of extubation until the date of discharging from the RICU up to 28 days)_
- **Mortality** _(time frame: Within 28 days after extubation)_
- **Partial pressure of arterial carbon dioxide** _(time frame: Within 24 hours before extubation and within 72 hours after extubation)_

## Locations (1)

- Xiangya Hospital, Changsha, Hunan, China

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.xiangya hospital|changsha|hunan|china` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT03928535.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT03928535*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*